Post Content
CVS Health Corporation (NYSE:CVS) is one of the best blue-chip stocks to buy for 2026. On January 6, CVS Health Corporation (NYSE:CVS)’s board approved a quarterly dividend of $0.665 a share. The dividend is to be paid on February 2, 2026, to shareholders of record as of January 22. It marks the 55th consecutive year that the company has rewarded investors with dividends, with the stock currently yielding 3.31%.
Source: Pexels
The dividend offering coincides with Cantor Fitzgerald reiterating CVS Health as its preferred stock for Medicare Advantage exposure this year. According to the research firm, the company remains well-positioned to benefit from a favorable regulatory environment.
Likewise, Bernstein raised its price target for the stock to $87 from $86 while reiterating a Market Perform rating. The price target hike is in response to the research firm’s touting of the successful execution of a turnaround strategy. The research firm also views Aetna as an attractive growth engine expected to drive future performance despite headwinds in the pharmacy benefit environment. Bernstein expects CVS to benefit from growth in pharmacy benefit managers alongside an increase in drug spend.
CVS Health Corporation (NYSE:CVS) is a major U.S. healthcare company that integrates retail pharmacies (CVS Pharmacy), health insurance (Aetna), and pharmacy benefits management (CVS Caremark) to provide a connected health experience, offering everything from prescriptions and wellness products to insurance plans.
While we acknowledge the potential of CVS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 10 Best Penny Stocks to Buy for 2026 and 10 Best Metal Stocks to Buy Right Now.
Disclosure: None. This article is originally published at Insider Monkey.